PharmaBlock Sciences Nanjing Inc Class A (300725) — Strategic Asset Allocation Index
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Strategic Asset Allocation Index of 62.4% as of June 2023. Strategic assets (PP&E of CN¥1.73 Billion plus long-term investments of CN¥-) total CN¥1.73 Billion, measured against net assets of CN¥2.77 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check asset resilience ratio of PharmaBlock Sciences Nanjing Inc Class A to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
PharmaBlock Sciences Nanjing Inc Class A Strategic Asset Allocation Index (2016–2022)
This chart shows how PharmaBlock Sciences Nanjing Inc Class A's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 62.4%, representing strategic assets of CN¥1.73 Billion against net assets of CN¥2.77 Billion CNY. See financial flexibility index of PharmaBlock Sciences Nanjing Inc Class A to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for PharmaBlock Sciences Nanjing Inc Class A (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for PharmaBlock Sciences Nanjing Inc Class A from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PharmaBlock Sciences Nanjing Inc Class A stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.5% | CN¥1.66 Billion | CN¥1.66 Billion | CN¥- | CN¥2.66 Billion | ▲ +17.9 pp |
| 2021 | 44.6% | CN¥1.17 Billion | CN¥1.17 Billion | CN¥- | CN¥2.63 Billion | ▲ +28.3 pp |
| 2020 | 16.3% | CN¥309.36 Million | CN¥309.36 Million | CN¥- | CN¥1.89 Billion | ▼ -18.5 pp |
| 2019 | 34.8% | CN¥257.69 Million | CN¥257.69 Million | CN¥- | CN¥740.87 Million | ▲ +13.8 pp |
| 2018 | 21.0% | CN¥125.88 Million | CN¥125.88 Million | CN¥- | CN¥599.73 Million | ▲ +2.5 pp |
| 2017 | 18.5% | CN¥93.04 Million | CN¥93.04 Million | CN¥- | CN¥503.59 Million | ▼ -11.0 pp |
| 2016 | 29.5% | CN¥74.98 Million | CN¥74.98 Million | CN¥- | CN¥254.15 Million | — |